EXEL
Exelixis Inc
Price:  
21.53 
USD
Volume:  
2,637,810.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL WACC - Weighted Average Cost of Capital

The WACC of Exelixis Inc (EXEL) is 7.2%.

The Cost of Equity of Exelixis Inc (EXEL) is 10.45%.
The Cost of Debt of Exelixis Inc (EXEL) is 5.00%.

Range Selected
Cost of equity 8.80% - 12.10% 10.45%
Tax rate 20.60% - 21.80% 21.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 8.0% 7.2%
WACC

EXEL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.06 1.29
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 12.10%
Tax rate 20.60% 21.80%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 8.0%
Selected WACC 7.2%